The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Strengthening capabilities in Peptide Therapeutics and CDMO services
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
USFDA inspection at Alembic Pharma's Bioequivalence facility
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Total Income during Q3 FY25 stood at Rs. 527.37 crore as compared to Rs. 528.77 crore in Q3 FY24
Subscribe To Our Newsletter & Stay Updated
